ANDREW OLGUIN: Open Payments
NPI 1417546102 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 10 payments from 9 companies in 2025. Trend: 2023 $414 · 2024 $368 · 2025 $204
Food & beverage: $189Education: $15
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Celgene Corporation | 1 | $24 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Geron Corporation | 1 | $17 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
Products named: KEYTRUDA, Vyloy, REBLOZYL, LONSURF, Lenvima, LIBTAYO, RYTELO, FOTIVDA.
Industry payments across TX — which companies pay providers there.
